Medtronic plc (MDT)
USD 81.88
(-1.53%)
USD 81.88
(-1.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 23.87 Billion USD | -1.69% |
| 2023 | 24.34 Billion USD | 19.5% |
| 2022 | 20.37 Billion USD | -22.77% |
| 2021 | 26.37 Billion USD | 19.79% |
| 2020 | 22.02 Billion USD | -10.07% |
| 2019 | 24.48 Billion USD | 3.32% |
| 2018 | 23.69 Billion USD | -8.57% |
| 2017 | 25.92 Billion USD | -14.3% |
| 2016 | 30.24 Billion USD | -10.38% |
| 2015 | 33.75 Billion USD | 227.21% |
| 2014 | 10.31 Billion USD | 0.23% |
| 2013 | 10.29 Billion USD | 39.84% |
| 2012 | 7.35 Billion USD | -9.28% |
| 2011 | 8.11 Billion USD | 16.82% |
| 2010 | 6.94 Billion USD | 2.54% |
| 2009 | 6.77 Billion USD | 16.72% |
| 2008 | 5.8 Billion USD | 4.02% |
| 2007 | 5.57 Billion USD | 1.67% |
| 2006 | 5.48 Billion USD | 178.04% |
| 2005 | 1.97 Billion USD | 179281.82% |
| 2004 | 1.1 Million USD | -99.94% |
| 2003 | 1.98 Billion USD | 20745.26% |
| 2002 | 9.5 Million USD | -28.57% |
| 2001 | 13.3 Million USD | -5.67% |
| 2000 | 14.1 Million USD | -19.89% |
| 1999 | 17.6 Million USD | 8.64% |
| 1998 | 16.2 Million USD | 15.71% |
| 1997 | 14 Million USD | -8.5% |
| 1996 | 15.3 Million USD | 7.75% |
| 1995 | 14.2 Million USD | -29.7% |
| 1994 | 20.2 Million USD | 85.32% |
| 1993 | 10.9 Million USD | 26.74% |
| 1992 | 8.6 Million USD | 8.86% |
| 1991 | 7.9 Million USD | -1.25% |
| 1990 | 8 Million USD | 2.56% |
| 1989 | 7.8 Million USD | -14.29% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 23.74 Billion USD | -2.95% |
| 2024 Q1 | 24.46 Billion USD | 0.49% |
| 2024 FY | 23.87 Billion USD | -1.92% |
| 2024 Q3 | 24.09 Billion USD | 1.74% |
| 2024 Q4 | 23.87 Billion USD | -0.91% |
| 2023 FY | 24.34 Billion USD | 19.5% |
| 2023 Q4 | 24.34 Billion USD | 9.61% |
| 2023 Q2 | 20.69 Billion USD | 18.8% |
| 2023 Q1 | 17.42 Billion USD | -14.24% |
| 2023 Q3 | 22.21 Billion USD | 7.31% |
| 2022 FY | 20.37 Billion USD | -22.77% |
| 2022 Q2 | 25.6 Billion USD | -1.35% |
| 2022 Q3 | 24.29 Billion USD | -5.14% |
| 2022 Q4 | 20.31 Billion USD | -16.36% |
| 2022 Q1 | 25.95 Billion USD | -1.59% |
| 2021 Q3 | 26.5 Billion USD | 2.06% |
| 2021 Q1 | 22.86 Billion USD | 3.84% |
| 2021 Q4 | 26.37 Billion USD | -0.47% |
| 2021 FY | 26.37 Billion USD | 19.79% |
| 2021 Q2 | 25.96 Billion USD | 13.56% |
| 2020 Q1 | 24.8 Billion USD | 1.3% |
| 2020 Q3 | 24.73 Billion USD | -0.08% |
| 2020 Q2 | 24.75 Billion USD | -0.21% |
| 2020 FY | 22.02 Billion USD | -10.07% |
| 2020 Q4 | 22.02 Billion USD | -10.96% |
| 2019 Q3 | 23.67 Billion USD | 0.0% |
| 2019 Q2 | 23.67 Billion USD | -0.02% |
| 2019 Q1 | 23.67 Billion USD | -0.09% |
| 2019 Q4 | 24.48 Billion USD | 3.43% |
| 2019 FY | 24.48 Billion USD | 3.32% |
| 2018 Q3 | 25.91 Billion USD | -0.09% |
| 2018 FY | 23.69 Billion USD | -8.57% |
| 2018 Q2 | 25.94 Billion USD | -0.05% |
| 2018 Q4 | 23.69 Billion USD | -8.56% |
| 2018 Q1 | 25.95 Billion USD | 0.12% |
| 2017 Q4 | 25.92 Billion USD | -0.01% |
| 2017 FY | 25.92 Billion USD | -14.3% |
| 2017 Q3 | 25.92 Billion USD | -10.64% |
| 2017 Q2 | 29.01 Billion USD | -3.7% |
| 2017 Q1 | 30.12 Billion USD | -0.41% |
| 2016 Q2 | 33.69 Billion USD | -0.06% |
| 2016 Q3 | 33.68 Billion USD | -0.03% |
| 2016 Q4 | 30.24 Billion USD | -10.2% |
| 2016 FY | 30.24 Billion USD | -10.38% |
| 2016 Q1 | 33.7 Billion USD | -0.13% |
| 2015 Q3 | 26.55 Billion USD | 173.56% |
| 2015 Q2 | 9.7 Billion USD | -5.96% |
| 2015 Q1 | 10.32 Billion USD | 0.08% |
| 2015 FY | 33.75 Billion USD | 227.21% |
| 2015 Q4 | 33.75 Billion USD | 27.09% |
| 2014 Q1 | 9.63 Billion USD | -6.36% |
| 2014 Q4 | 10.31 Billion USD | 7.44% |
| 2014 Q3 | 9.6 Billion USD | -0.37% |
| 2014 FY | 10.31 Billion USD | 0.23% |
| 2014 Q2 | 9.63 Billion USD | 0.0% |
| 2013 Q3 | 7.31 Billion USD | -0.56% |
| 2013 Q4 | 10.29 Billion USD | 40.7% |
| 2013 Q1 | 7.38 Billion USD | 0.37% |
| 2013 Q2 | 7.35 Billion USD | -0.42% |
| 2013 FY | 10.29 Billion USD | 39.84% |
| 2012 Q1 | 8.19 Billion USD | 1.02% |
| 2012 Q3 | 8.24 Billion USD | 0.32% |
| 2012 Q4 | 7.35 Billion USD | -10.78% |
| 2012 FY | 7.35 Billion USD | -9.28% |
| 2012 Q2 | 8.22 Billion USD | 0.33% |
| 2011 Q2 | 7.14 Billion USD | 0.96% |
| 2011 Q1 | 7.08 Billion USD | 1.96% |
| 2011 FY | 8.11 Billion USD | 16.82% |
| 2011 Q4 | 8.11 Billion USD | 14.51% |
| 2011 Q3 | 7.08 Billion USD | -0.9% |
| 2010 Q2 | 6.36 Billion USD | 0.97% |
| 2010 FY | 6.94 Billion USD | 2.54% |
| 2010 Q1 | 6.3 Billion USD | -6.87% |
| 2010 Q4 | 6.94 Billion USD | 8.57% |
| 2010 Q3 | 6.39 Billion USD | 0.44% |
| 2009 Q2 | 5.52 Billion USD | 0.44% |
| 2009 Q4 | 6.77 Billion USD | 22.57% |
| 2009 Q3 | 5.52 Billion USD | 0.04% |
| 2009 Q1 | 5.49 Billion USD | -5.22% |
| 2009 FY | 6.77 Billion USD | 16.72% |
| 2008 Q3 | 5.65 Billion USD | 2.95% |
| 2008 FY | 5.8 Billion USD | 4.02% |
| 2008 Q1 | 5.57 Billion USD | -0.04% |
| 2008 Q4 | 5.8 Billion USD | 2.58% |
| 2008 Q2 | 5.49 Billion USD | -1.47% |
| 2007 FY | 5.57 Billion USD | 1.67% |
| 2007 Q3 | 5.57 Billion USD | -0.07% |
| 2007 Q4 | 5.57 Billion USD | 0.02% |
| 2007 Q2 | 5.58 Billion USD | 1.75% |
| 2007 Q1 | 5.48 Billion USD | -0.02% |
| 2006 Q3 | 1 Billion USD | 0.13% |
| 2006 Q1 | 1.97 Billion USD | -0.01% |
| 2006 Q2 | 1 Billion USD | -49.25% |
| 2006 FY | 5.48 Billion USD | 178.04% |
| 2006 Q4 | 5.48 Billion USD | 447.26% |
| 2005 Q2 | 1.97 Billion USD | 123325.0% |
| 2005 Q1 | 1.6 Million USD | 45.45% |
| 2005 FY | 1.97 Billion USD | 179281.82% |
| 2005 Q3 | 1.97 Billion USD | 0.01% |
| 2005 Q4 | 1.97 Billion USD | -0.09% |
| 2004 FY | 1.1 Million USD | -99.94% |
| 2004 Q1 | 1.97 Billion USD | -0.04% |
| 2004 Q2 | 2.1 Million USD | -99.89% |
| 2004 Q3 | 2.1 Million USD | 0.0% |
| 2004 Q4 | 1.1 Million USD | -47.62% |
| 2003 FY | 1.98 Billion USD | 20745.26% |
| 2003 Q2 | 1.98 Billion USD | 20344.33% |
| 2003 Q3 | 1.98 Billion USD | 0.05% |
| 2003 Q4 | 1.98 Billion USD | -0.19% |
| 2003 Q1 | 9.7 Million USD | 2.11% |
| 2002 Q2 | 14.1 Million USD | 1.44% |
| 2002 FY | 9.5 Million USD | -28.57% |
| 2002 Q4 | 9.5 Million USD | -30.15% |
| 2002 Q3 | 13.6 Million USD | -3.55% |
| 2002 Q1 | 13.9 Million USD | 4.51% |
| 2001 Q3 | 15.9 Million USD | 6.0% |
| 2001 Q4 | 13.3 Million USD | -16.35% |
| 2001 Q1 | 15.5 Million USD | 9.93% |
| 2001 Q2 | 15 Million USD | -3.23% |
| 2001 FY | 13.3 Million USD | -5.67% |
| 2000 Q1 | 18.9 Million USD | 7.39% |
| 2000 FY | 14.1 Million USD | -19.89% |
| 2000 Q2 | 18.1 Million USD | -4.23% |
| 2000 Q3 | 24.4 Million USD | 34.81% |
| 2000 Q4 | 14.1 Million USD | -42.21% |
| 1999 FY | 17.6 Million USD | 8.64% |
| 1999 Q3 | 22.6 Million USD | 15.9% |
| 1999 Q1 | 16.4 Million USD | 1.23% |
| 1999 Q2 | 19.5 Million USD | 18.9% |
| 1999 Q4 | 17.6 Million USD | -22.12% |
| 1998 Q2 | 16.1 Million USD | -14.81% |
| 1998 Q1 | 18.9 Million USD | 35.0% |
| 1998 Q3 | 15.5 Million USD | -3.73% |
| 1998 FY | 16.2 Million USD | 15.71% |
| 1998 Q4 | 16.2 Million USD | 4.52% |
| 1997 FY | 14 Million USD | -8.5% |
| 1997 Q3 | 17.7 Million USD | -13.24% |
| 1997 Q4 | 14 Million USD | -20.9% |
| 1997 Q2 | 20.4 Million USD | 6.81% |
| 1997 Q1 | 19.1 Million USD | 24.84% |
| 1996 FY | 15.3 Million USD | 7.75% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | 15.3 Million USD | 0.0% |
| 1996 Q1 | - USD | -100.0% |
| 1995 Q1 | - USD | -100.0% |
| 1995 FY | 14.2 Million USD | -29.7% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | 14.2 Million USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | 20.2 Million USD | 85.32% |
| 1994 Q4 | 20.2 Million USD | 0.0% |
| 1994 Q1 | - USD | -100.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q4 | 10.9 Million USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | -100.0% |
| 1993 FY | 10.9 Million USD | 26.74% |
| 1992 Q1 | - USD | -100.0% |
| 1992 Q4 | 8.6 Million USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 FY | 8.6 Million USD | 8.86% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | -100.0% |
| 1991 FY | 7.9 Million USD | -1.25% |
| 1991 Q4 | 7.9 Million USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1990 FY | 8 Million USD | 2.56% |
| 1990 Q4 | 8 Million USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1989 FY | 7.8 Million USD | -14.29% |
| 1989 Q4 | 7.8 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | -75.579% |
| Allurion Technologies Inc. | 2.3 Million USD | -1035329.315% |
| Artivion, Inc. | 305.53 Million USD | -7714.919% |
| Avanos Medical, Inc. | 159.4 Million USD | -14879.297% |
| Butterfly Network, Inc. | 22.83 Million USD | -104463.171% |
| Butterfly Network, Inc. | 22.83 Million USD | -104463.171% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | -1907.395% |
| Boston Scientific Corporation | 8.96 Billion USD | -166.455% |
| CONMED Corporation | 971.48 Million USD | -2357.789% |
| Edwards Lifesciences Corporation | 670 Million USD | -3463.731% |
| Paragon 28, Inc. | 109.79 Million USD | -21646.1% |
| Glaukos Corporation | 383.73 Million USD | -6122.214% |
| Globus Medical, Inc. | 417.4 Million USD | -5620.412% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -95999.976% |
| Integer Holdings Corporation | 959.92 Million USD | -2387.382% |
| Myomo, Inc. | 115.16 Thousand USD | -20733661.723% |
| Nevro Corp. | 211.47 Million USD | -11190.91% |
| Owlet, Inc. | 22 Thousand USD | -108531718.182% |
| Penumbra, Inc. | 220.9 Million USD | -10708.523% |
| Vicarious Surgical Inc. | 13.78 Million USD | -173110.011% |
| Smith & Nephew plc | 2.17 Billion USD | -997.793% |
| Sonendo, Inc. | 14.03 Million USD | -170024.688% |
| STERIS plc | 3.12 Billion USD | -665.249% |
| Stryker Corporation | 10.9 Billion USD | -119.035% |
| Vapotherm, Inc. | 109.97 Million USD | -21610.706% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | -390.499% |